Clinical Trial Update: Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of gemcitabine combined with oxaliplatin for recurrent or metastatic breast cancer; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: University of Southern California | Conditions: Recurrent Breast Cancer, Metastastic Breast Cancer | Phase 2 | Status: TERMINATED